A $300 million settlement has been reached in the multidistrict Benicar litigation against Daiichi Sankyo Inc. and Forest Laboratories Inc. on claims that the top-selling blood pressure drug caused severe, and sometimes life-threatening, gastrointestinal injuries in users. [Read more…]
Lieff Cabraser attorney Lexi J. Hazam is speaking at HarrisMartin’s MDL Conference: Zofran, Bard IVC and Zimmer Persona Knee Litigation on July 29, 2015 at Hotel Nikko in San Francisco. Hazam will be featured as a panelist discussing the Benicar (Olmesartan) Litigation. Hazam has been appointed by the court overseeing the nationwide Benicar MDL litigation to the Plaintiffs’ Steering Committee, and serves as Co-Chair of the MDL Plaintiffs’ Science and Experts Committee.
Lieff Cabraser attorney Lexi J. Hazam will be speaking at HarrisMartin’s MDL Conference: Xarelto, Morcellators and Emerging Torts on March 25, 2015 at The Westin San Diego. Hazam will be featured on a panel discussing the prescription drug Benicar. Hazam will also be addressing the science behind the plaintiffs’ claims.